×

Dr. Lohith G

Dr. Lohith G

Dr. Lohith G

QualificationMBBS,DNB (Radiation Oncology ),F-ESMO

Specialities Radiation Oncology

Locations HCG Cancer Center - KR BLRHCG Cancer Center - DR BLR
Book an Appointment

Area of Expertise

●        Dr. Lohith Reddy is a distinguished radiation oncologist practicing at HCG Cancer Centre, a top cancer hospital in Bangalore.

●        He specializes in the management of benign brain and spinal tumors through CyberKnife SBRT and SRS. He treats disseminated diseases using a multidisciplinary, targeted approach.

●        Dr. Lohith Reddy is well-versed in the domains of artificial intelligence, radiomics, and radio-genomics, all of which are crucial for personalized cancer therapy. He is trained in advanced radiotherapy techniques, including:

-          3D Conformal Radiotherapy (3D CRT)

-          Intensity-Modulated Radiotherapy (IMRT)

-          Image-Guided Radiotherapy (IGRT)

-          Stereotactic Adaptive Radiotherapy (SART)

-          Stereotactic Body Radiotherapy (SBRT)

-          Proton Therapy

-          Carbon Ion Therapy

-          Brachytherapy

  • Dr. Lohith’s collaborative and patient-centric approach, combined with his cutting-edge expertise and global training, ensures that patient outcomes remain at the heart of his practice.

Research & Publications

●       Dr. Lohith Reddy has an extensive publication record, with over 60 papers in top international journals and multiple textbook chapters. He has presented his work at prestigious conferences worldwide, including: 

- Reality Cancer Mapping, Vienna, Austria

- Immuno-Radiotherapy Combinations, New York, USA

- Precision Oncology, ASTRO, Washington, USA

Medical Breakthrough

●        Dr. Lohith Reddy is leading radiomics and radio-genomics efforts at HCG for personalized cancer treatment.

●        Dr. Lohith Reddy was the first in India to implement CyberKnife stereotactic radiosurgery (SRS) and SBRT as potent enhancers of immunotherapy.

●        He organized the first Asian-African conference on Rad-Immunotherapy combinations, positioning HCG as a pioneering center for this program in the region.

●        Dr. Lohith Reddy has played an instrumental role in the development of multiple Immune-Rad combinations for disseminated cancers.

●        His research extends into the realms of genomics in radiation, metabolic diets in radiation therapy, and the use of theranostics to manipulate the tumor microenvironment.

●        Dr. Lohith Reddy has treated the highest number of patients in Asia and Africa using AI-based online adaptive treatment with Ethos Adaptive Radiation Therapy.

Awards & Accolades

●       Recognitions:

- Research Award from the European Society for Medical Oncology (ESMO)

- Research Award from the Society of Neuro-oncology, Scottsdale, USA

- Invited Fellow at Essen Proton Therapy Center and CNAO, Pavia, Italy

 

●       Grants and Leadership:

  • Dr. Lohith Reddy is the principal investigator for a major AI trial in head and neck cancer decision support systems, collaborating with Maastricht University. He has secured over $1 million in grants from Siemens, Philips, and Varian to develop biomarkers and genomic-based radiation therapy.

    ●       Invited Faculty and Collaborations:

    - Harvard Business School, Boston, USA: Precision Oncology and its Impact in the Developing World

    - Collaborations with global leaders in technology and clinical research to push the boundaries of cancer treatment

Other Doctors